Format

Send to

Choose Destination
Int J Lab Hematol. 2018 May;40 Suppl 1:30-33. doi: 10.1111/ijlh.12816.

Direct oral anticoagulants: When to consider laboratory testing?

Author information

1
Department of Internal Medicine, Maastricht University, Maastricht, The Netherlands.
2
Heart and Vascular Center, Thrombosis Expert Center, Maastricht University, Maastricht, The Netherlands.
3
Center for Thrombosis and Haemostasis, Gutenberg University Medical Center, Mainz, Germany.
4
CARIM Cardiovascular Research School, Maastricht University, Maastricht, The Netherlands.
5
Central Diagnostic Laboratory, Maastricht University Medical Center, Maastricht University, Maastricht, The Netherlands.

Abstract

INTRODUCTION:

Direct oral anticoagulants (DOACs) are increasingly prescribed for prevention of thromboembolic stroke, as well as for prevention and treatment of venous thromboembolism. Dose adjustment based on laboratory testing is not required; however, there are several potential situations that deserve insight into a DOAC plasma activity level.

METHODS:

Based on a series of real-life case descriptions, we discuss indications for dedicated DOAC testing, as well as the interpretation and consequences.

RESULTS:

Testing of DOACs in selected patients may help to better interpret acute situations such as bleeding or thrombosis while on anticoagulation, but also suspected drug failure, drug accumulation, or lack of adherence.

CONCLUSION:

The 24/7 availability of target-specific tests with adequate calibration is recommended to support the clinician in the interpretation and where needed adjustment of the management of patients on DOACs. The relevance of laboratory-guided DOAC management, particularly in the elderly, merits further study.

KEYWORDS:

anticoagulation; bleeding; direct oral anticoagulant; laboratory assay; thrombosis

PMID:
29741249
DOI:
10.1111/ijlh.12816
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center